ASYLIA THERAPEUTICS
Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases. The company's platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has produced unprecedented anti-tumor responses across multiple cancer models. Asylia Therapeutics was founded in 2019 in Houston, Texas.
ASYLIA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.asyliatx.com
Total Employee:
1+
Status:
Active
Total Funding:
22.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Current Employees Featured
Jeno Gyuris
Jeno Gyuris Executive Vice President and Chief Scientific Officer @ Asylia Therapeutics Executive Vice President and Chief Scientific Officer
Ronald A. DePinho
Ronald A. DePinho Co-Founder & Co-Chair @ Asylia Therapeutics Co-Founder & Co-Chair
Robert Z. Orlowski
Robert Z. Orlowski Co-Founder and Co-Chair @ Asylia Therapeutics Co-Founder and Co-Chair
Richard Jones
Richard Jones Co-Founder @ Asylia Therapeutics Co-Founder
Founder
Richard Jones
Robert Z. Orlowski
Ronald A. DePinho
Investors List
Sporos Bioventures
Sporos Bioventures investment in Series A - Asylia Therapeutics
Official Site Inspections
http://www.asyliatx.com Semrush global rank: 5.9 M Semrush visits lastest month: 1.4 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...